At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
In Brief
A clinical study evaluating Omega 3 fatty acids and Placebo for Autism. Completed, enrolled 17 participants across 1 site.
Detailed Summary
Published studies on omega 3 fatty acids in the treatment of bipolar disorder and schizophrenia have shown reductions in time to recurrence, a decrease in the positive and negative symptoms of schizophrenia, and improvements in Clinical Global Impression Scale, Young Mania Rating Scale, and HAM-D scores. The following are the hypotheses: * Omega 3 fatty acids will be superior to placebo in the acute treatment of global autism. * Omega 3 fatty acids will be superior to placebo in improving aggression and irritability associated with autism. * Omega 3 fatty acids will be superior to placebo in improving functional ability.
Study Details
Timeline
Interventions
The study will start with low doses and based on the weight of the individual the dosage will be increased biweekly.
Same dosage as that of omega 3 fatty acids